![]() |
Volumn 92, Issue 1-3, 2007, Pages 273-275
|
Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: An open-labeled trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORPROMAZINE;
CLOZAPINE;
HALOPERIDOL;
HUPERZINE A;
LITHIUM;
NEUROLEPTIC AGENT;
OLANZAPINE;
PERPHENAZINE;
QUETIAPINE;
RISPERIDONE;
VALPROIC ACID;
ADD ON THERAPY;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DISEASE DURATION;
DRUG EFFICACY;
DRUG WITHDRAWAL;
HUMAN;
LETTER;
MINI MENTAL STATE EXAMINATION;
NEGATIVE SYNDROME;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
RATING SCALE;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADOLESCENT;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
CHLORPROMAZINE;
CHOLINESTERASE INHIBITORS;
CLOZAPINE;
DRUG RESISTANCE;
DRUG SYNERGISM;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
RISPERIDONE;
SCHIZOPHRENIA;
SESQUITERPENES;
|
EID: 34147161138
PISSN: 09209964
EISSN: None
Source Type: Journal
DOI: 10.1016/j.schres.2007.02.005 Document Type: Letter |
Times cited : (11)
|
References (8)
|